Catalogue 2021

Total Page:16

File Type:pdf, Size:1020Kb

Catalogue 2021 Header Future Science Group Catalogue 2021 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science Group 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital Hubs 8 ........................................................................................................................................ Sponsorship Opportunities 9 ........................................................................................................................................ Testimonials 9 ........................................................................................................................................ 1 Our Journal Portfolio Our Journal Portfolio Future Science Group (FSG) is an independent publisher, based in London, with an expanding and diverse group of journals in cutting-edge areas of postgenomic scientific and medical information. FSG houses three imprints; Future Medicine, Future Science and Newlands Press. All journals are peer reviewed and many are also indexed on MEDLINE, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, EMBASE, Chemical Abstracts, DOAJ, PubMed Central and Scopus. We also offer DRM-free perpetual access to a wide variety of eBook collections. ALL PUBLICATIONS ARE: ORIGINAL AND TIMELY Blending commissioned and unsolicited content, including reviews, research and commentaries, to ensure that readers are kept comprehensively up-to-date with the latest advances and techniques in bioscience and clinical practice, whatever their discipline. SUPPORTED BY STRONG EDITORIAL STANDARDS All journals are underpinned by robust double-blind peer review ensuring only articles of the highest quality are published. Authors benefit from a supportive in-house editorial team, taking them from pre-submission enquiries, right through to publication and beyond. VISIBLE AND ACCESSIBLE GLOBALLY To ensure 24/7 access and maximum discoverability, all of our titles are hosted by Atypon on industry-leading websites. 2 For more information visit www.future-science-group.com Future Medicine At-A-Glance FUTURE MEDICINE AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioelectronics in Medicine No n/a 4 2018 Biomarkers in Medicine Yes 2.268 18 2007 Breast Cancer Management No n/a Rolling 2012 CNS Oncology Yes n/a Rolling 2012 Colorectal Cancer No n/a Rolling 2012 Concussion PMC-indexed n/a Rolling 2015 Epigenomics Yes 4.404 24 2009 Future Cardiology Yes n/a 6 2005 Future Microbiology Yes 2.746 18 2006 Future Neurology No n/a Rolling 2006 Future Oncology Yes 2.279 36 2005 Future Virology No 0.730 12 2006 Hepatic Oncology PMC-indexed n/a Rolling 2014 Immunotherapy Yes 3.028 18 2009 International Journal of Endocrine Oncology No n/a Rolling 2014 International Journal of Hematologic Oncology PMC-indexed n/a Rolling 2012 Journal of 3D Printing in Medicine No n/a 4 2017 Journal of Comparative Effectiveness Research Yes 1.485 18 2012 Lung Cancer Management PMC-indexed n/a Rolling 2012 Melanoma Management PMC-indexed n/a Rolling 2014 Nanomedicine Yes 4.717 30 2006 Neurodegenerative Disease Management Yes n/a 6 2011 Pain Management Yes n/a 6 2011 Personalized Medicine Yes 1.414 6 2004 Pharmacogenomics Yes 2.265 18 2000 Regenerative Medicine Yes 2.383 12 2006 : Open access; PMC: PubMed Central. 3 SectionFuture Science Header and Newlands Press At-A-GlanceFuture Science FUTURE SCIENCE AND NEWLANDS PRESS AT-A-GLANCE Journal MEDLINE- Impact factor Frequency Launch indexed (2018) year Bioanalysis Yes 2.321 24 2009 BioTechniques Yes 1.659 12 1983 Future Drug Discovery No n/a Quarterly 2019 Future Medicinal Chemistry Yes 3.617 24 2009 Future Science OA PMC-indexed n/a Rolling 2015 International Journal of Pharmacokinetics No n/a 4 2016 Pharmaceutical Patent Analyst Yes n/a 6 2012 Therapeutic Delivery Yes n/a 12 2010 : Open access; PMC: PubMed Central. EBOOK COLLECTIONS We offer DRM-free perpetual access to a wide variety of eBook collections. 55 35 15 ONCOLOGY NEUROLOGY BIOMEDICINE 31 153 51 IMMUNOLOGY 15 CLINICAL DRUG R&D & INFECTIOUS CARDIOLOGY MEDICINE DISEASE 4 For more information visit www.future-science-group.com New to Future Science Group VIDEO JOURNAL OF BIOMEDICINE The Video Journal of Biomedicine provides readers with short, high-quality, interview- style videos with authors of recently published, peer-reviewed papers. All videos are professionally filmed and produced by our in-house team and published open access on a dedicated platform. Each video provides the opportunity for authors to personally discuss their latest published work in more detail; highlighting its importance to the field, placing it in context, and discussing future implications. More information is available at: www.biomedicine.video PHARMAPLATFORMS armaPlatforms PUBLISH ENRICH REACH ENGAGE PharmaPlatforms is the creative arm of FSG, building comprehensive, collaborative communication plans around published content and scientific information. By providing a range of platforms and solutions, we enable timely and accessible publication that enriches the information presented, engages the reader, and reaches a broad, scientific and medical professional audience. Find out more at: www.pharmaplatforms.com 5 Information for Librarians INSTITUTIONAL & ACADEMIC SUBSCRIPTIONS Academic pricing is set regardless of size or number of sites. All academic institutions receive 5 years of content. For a quote, contact [email protected]. CORPORATE Corporate pricing is set depending on the size of the company and the number of sites. Corporate institutions receive 2 years of content (backfiles of content are available on request). CONSORTIA FSG works with consortia of various types and sizes, and welcomes discussion with all consortium managers. COUNTER-compliant usage statistics are provided for each institution. The benefits for the consortium include discounts on list price. Members have the flexibility to select the publications they want to include, or FSG will work with the consortium to create customized packages. INDEXING FSG titles are abstracted and indexed in all the main databases including MEDLINE/ Index Medicus, EMBASE/Excerpta Medica, Scopus, Clarivate’s Science Citation Index Expanded and Emerging Sources Citation Index, DOAJ, PubMed Central and Chemical Abstracts. 6 For more information visit www.future-science-group.com Institutional Trials Institutional Trials INSTITUTIONAL TRIALS If you would like to trial our content, simply get in touch at: [email protected]. Trials can be to single publications or entire collections; the choice is yours. We will work with you to decide on the best time and duration for your institution. DURING THE PERIOD, YOU HAVE: • Full-text access to the titles you select • Detailed usage statistics from our Atypon-backed platform • Support from our in-house technical team • Control over the duration, visibility and promotion of the trial Fair usage limits apply. For more details, contact [email protected] SERVICES • Flexible purchasing • Accessible for all institution types • COUNTER-compliant usage reports • ATHENS & Shibboleth authentication compliant • Reliable publishing platform • Dynamic customer services • Promotion tools on request • Collection leasing 7 Digital Hubs DIGITAL HUBS In addition to our journal content, FSG publishes nine digital hubs, which enable professionals to easily connect and collaborate with their peers in niche scientific fields. Enriched with high-value expert insight and integration with social media, our hubs provide a route to further broadcast content published in our associated publications. 3DMedNet Neuro Central Covering 3D printing and bioprinting in Uniting all aspects of neurology and medicine and healthcare neuroscience www.3dmednet.com www.neuro-central.com Bioanalysis Zone Oncology Central Market-leading online resource for the global bioanalytical community Delivering the latest news and insights in the fast-moving field of oncology www.bioanalysis-zone.com www.oncology-central.com BioTechniques The latest methods, techniques and protocols for the life science research RegMedNet community The latest research on all regenerative www.biotechniques.com medicine topics from stem cells to regenerative pharmaceuticals Te Evidencewww.regmednet.com The Evidence Base BaseTM Covering the latest news, opinion and insight into the collection and application of
Recommended publications
  • Some Thoughts on Writing and Reviewing Scientific Articles
    Elsevier-sponsored workshop held at the 25th Congress of the International Society of Forensic Genetics (ISFG) Scientific Publication: Reading, Writing, and Reviewing John M. Butler, PhD U.S. National Institute of Standards and Technology (NIST) Associate Editor, Forensic Science International: Genetics Melbourne, Australia 5 September 2013 Presentation Outline The 3 R’s of Scientific Publication: Reading, (Re-)Writing, and Reviewing • Introduction • Reading – Tools for reference collection • Writing – Submission & peer-review process • Reviewing • FSI Genetics Target Audience for This Presentation • Young (or even more seasoned) scientists who want to learn how to write better or become a more effective reviewer • Anyone who wants to better understand the review process “Writing a manuscript is arguably the single most critical component to being a scientist – one for which, in many cases, formal training is minimal.” - Dr. Nathan Blow, BioTechniques editor-in-chief (May 2013, p. 235) My Qualifications on this Topic • Degrees in chemistry – BYU (B.S., 1992), University of Virginia (Ph.D., 1995) – Undergraduate classes on scientific writing and public speaking • Research-focused career E – Published ~150 articles and invited book chapters x – Given >300 presentations on scientific topics p e • Love for teaching r – Written four books (so far) on forensic DNA typing i e • Active reviewer and journal editor responsibilities n – Associate editor of Forensic Science International: Genetics since 2007 c – Reviewed hundreds of articles for
    [Show full text]
  • Biosafety and Health
    BIOSAFETY AND HEALTH AUTHOR INFORMATION PACK TABLE OF CONTENTS XXX . • Description p.1 • Abstracting and Indexing p.1 • Editorial Board p.1 • Guide for Authors p.6 ISSN: 2590-0536 DESCRIPTION . Biosafety and Health is an open access, peer-reviewed journal sponsored by the Chinese Medical Association, managed by National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC). This journal aims to publish original research findings and thoughts in any aspect connected with public health and biosafety. Topics include but are not limited to: Identification and characterization of biological threats; Origin, transmission, and evolution of biological agents; Surveillance, risk assessment, and early-warning; Prevention, diagnosis, and therapeutics; Synthetic biotechnology, genome editing, and other new biotechniques; Biosafety materials; Policies and standards. Biosafety and Health is published bimonthly in English language. Article types include Original Research, Reviews, Perspectives, Correspondence, Case Report, News and Views, Highlights, Comments and policy forum, etc. ABSTRACTING AND INDEXING . Directory of Open Access Journals (DOAJ) Scopus EDITORIAL BOARD . Editor-in-Chief Guizhen Wu, National Institute for Viral Disease Control and Prevention, Beijing, China Research on the prevention and control of infectious diseases, in addiiton to the treatment and traceability of major emergency infectious diseases, Research on the management of laboratory biosafety. Executive Editor-in-Chief
    [Show full text]
  • Future Science Group Catalogue 2020
    Header Future Science Group Catalogue 2020 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science Group 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital Hubs 8 ........................................................................................................................................ Sponsorship Opportunities 9 .......................................................................................................................................
    [Show full text]
  • Complaint Alleges That OMICS Group, Inc., Along with Two Affiliated Companies
    Case 2:16-cv-02022 Document 1 Filed 08/25/16 Page 1 of 54 1 DAVID C. SHONKA Acting General Counsel 2 IOANA RUSU GREGORY A. ASHE 3 Federal Trade Commission 4 600 Pennsylvania Avenue NW Washington, DC 20850 5 Telephone: 202-326-2077 (Rusu) Telephone: 202-326-3719 (Ashe) 6 Facsimile: 202-326-3768 7 Email: [email protected], [email protected] 8 DANIEL G. BOGDEN United States Attorney 9 BLAINE T. WELSH 10 Assistant United States Attorney Nevada Bar No. 4790 11 333 Las Vegas Blvd. South, Suite 5000 Las Vegas, Nevada 89101 12 Phone: (702) 388-6336 13 Facsimile: (702) 388-6787 14 Attorneys for Plaintiff 15 UNITED STATES DISTRICT COURT 16 DISTRICT OF NEVADA 17 FEDERAL TRADE COMMISSION, 18 Case No. 2:16-cv-02022 Plaintiff, 19 COMPLAINT FOR PERMANENT v. INJUNCTION AND OTHER 20 EQUITABLE RELIEF OMICS GROUP INC., a Nevada corporation, 21 also d/b/a OMICS Publishing Group, IMEDPUB 22 LLC, a Delaware corporation, CONFERENCE SERIES LLC, a Delaware corporation, and 23 SRINUBABU GEDELA, 24 Defendants. 25 26 Plaintiff, the Federal Trade Commission (“FTC”), for its Complaint alleges: 27 28 Page 1 of 16 Case 2:16-cv-02022 Document 1 Filed 08/25/16 Page 2 of 54 1 1. The FTC brings this action under Section 13(b) of the Federal Trade Commission Act 2 (“FTC Act”), 15 U.S.C. § 53(b) to obtain permanent injunctive relief, rescission or 3 reformation of contracts, restitution, the refund of monies paid, disgorgement of ill-gotten 4 monies, and other equitable relief for Defendants’ acts or practices in violation of 5 Section 5(a) of the FTC Act, 15 U.S.C.
    [Show full text]
  • A Workflow Using Open Access Tools and Concepts [Version 1; Peer Review: 1 Approved, 1 Approved with Reservations]
    F1000Research 2020, 9:1373 Last updated: 01 OCT 2021 SOFTWARE TOOL ARTICLE Effective image visualization for publications – a workflow using open access tools and concepts [version 1; peer review: 1 approved, 1 approved with reservations] Christopher Schmied 1*, Helena Klara Jambor 2* 1Leibniz-Forschungsinstitut für Molekulare Pharmakologie im Forschungsverbund Berlin e.V. (FMP), Berlin, Germany 2Mildred-Scheel Early Career Center, Medical Faculty, Technische Universität Dresden, Dresden, Germany * Equal contributors v1 First published: 26 Nov 2020, 9:1373 Open Peer Review https://doi.org/10.12688/f1000research.27140.1 Latest published: 18 Feb 2021, 9:1373 https://doi.org/10.12688/f1000research.27140.2 Reviewer Status Invited Reviewers Abstract Today, 25% of figures in biomedical publications contain images of 1 2 various types, e.g. photos, light or electron microscopy images, x-rays, or even sketches or drawings. Despite being widely used, published version 2 images may be ineffective or illegible since details are not visible, (revision) report information is missing or they have been inappropriately processed. 18 Feb 2021 The vast majority of such imperfect images can be attributed to the lack of experience of the authors as undergraduate and graduate version 1 curricula lack courses on image acquisition, ethical processing, and 26 Nov 2020 report report visualization. Here we present a step-by-step image processing workflow for effective and ethical image presentation. The workflow is aimed to 1. Guillaume Jacquemet , University of allow novice users with little or no prior experience in image Turku, Turku, Finland processing to implement the essential steps towards publishing images. The workflow is based on the open source software Fiji, but 2.
    [Show full text]
  • Future Science Group Catalogue 2019
    Header Future Science Group Catalogue 2019 Contact us Future Science Group Unitec House 2 Albert Place London, N3 1QB United kingdom +44(0)20 8371 6090 [email protected] [email protected] www.future-science-group.com @futuresciencegp future-science-group Future Science Group 1 Section Header 2 For more information visit www.future-science-group.com Contents Page Our Journal Portfolio 2 ........................................................................................................................................ Future Medicine At-A-Glance 3 ........................................................................................................................................ Future Science and Newlands Press At-A-Glance 4 ........................................................................................................................................ eBook Collections 4 ........................................................................................................................................ New to Future Science 5 ........................................................................................................................................ Information for Librarians 6 ........................................................................................................................................ Institutional Trials 7 ........................................................................................................................................ Digital
    [Show full text]
  • Journal List of Scopus.Xlsx
    Sourcerecord id Source Title (CSA excl.) (Medline-sourced journals are indicated in Green). Print-ISSN Including Conference Proceedings available in the scopus.com Source Browse list 16400154734 A + U-Architecture and Urbanism 03899160 5700161051 A Contrario. Revue interdisciplinaire de sciences sociales 16607880 19600162043 A.M.A. American Journal of Diseases of Children 00968994 19400157806 A.M.A. archives of dermatology 00965359 19600162081 A.M.A. Archives of Dermatology and Syphilology 00965979 19400157807 A.M.A. archives of industrial health 05673933 19600162082 A.M.A. Archives of Industrial Hygiene and Occupational Medicine 00966703 19400157808 A.M.A. archives of internal medicine 08882479 19400158171 A.M.A. archives of neurology 03758540 19400157809 A.M.A. archives of neurology and psychiatry 00966886 19400157810 A.M.A. archives of ophthalmology 00966339 19400157811 A.M.A. archives of otolaryngology 00966894 19400157812 A.M.A. archives of pathology 00966711 19400157813 A.M.A. archives of surgery 00966908 5800207606 AAA, Arbeiten aus Anglistik und Amerikanistik 01715410 28033 AAC: Augmentative and Alternative Communication 07434618 50013 AACE International. Transactions of the Annual Meeting 15287106 19300156808 AACL Bioflux 18448143 4700152443 AACN Advanced Critical Care 15597768 26408 AACN clinical issues 10790713 51879 AACN clinical issues in critical care nursing 10467467 26729 AANA Journal 00946354 66438 AANNT journal / the American Association of Nephrology Nurses and Technicians 07441479 5100155055 AAO Journal 27096 AAOHN
    [Show full text]
  • Scientific Publication Workshop
    Pre-Congress Workshop HW6 Scientific Publication: Reading, Writing, and Reviewing John M. Butler, Ph.D. NIST Fellow & Special Assistant to the Director for Forensic Science U.S. National Institute of Standards and Technology Associate Editor, Forensic Science International: Genetics 10 September 2019 Acknowledgments and Disclaimer Points of view are mine and do not necessarily represent the official position or policies of the National Institute of Standards and Technology or of Forensic Science International: Genetics or the Journal of Forensic Sciences (where I serve on editorial boards). Certain commercial entities are identified in order to specify experimental procedures as completely as possible. In no case does such identification imply a recommendation or endorsement by the National Institute of Standards and Technology, nor does it imply that any of the entities identified are necessarily the best available for the purpose. Value of Studying this Topic “Without publication, science is dead.” http://www.rolexawards.com/FILE/5069.jpg Gerard Piel (1915 – 2004) Publisher of Scientific American magazine “A scientific experiment is not complete until the results have been published and understood.” - Robert A. Day Some Topics We Hope to Address • How to find the best articles to answer my questions or to strengthen my research efforts • How to gain the most from articles that I read • How to store articles that I collect so I can find them again • How to review or become a better peer-reviewer • How to write or to improve my writing
    [Show full text]
  • Science Citation Index (SCI) Journals Related to "Biological Sciences" + Following Journals That May Or May Not Be Included in SCI
    FORMAT FOR SUBJECTWISE IDENTIFYING JOURNALS BY THE UNIVERSITIES AND APPROVAL OF THE UGC {Under Clause 6.05 (1) of the University Grants Commission (Minimum Qualifications for appointment of Teacher and Other Academic Staff in Universities and Colleges and Measures for the Maintenance of Standards in Higher Education (4th Amendment), Regulations, 2016} Subject: BOTANY, INSTITUTE OF SCIENCE, BHU A. Refereed Journals Sl. Name of the Journal Publisher and Year of Hard e-publication ISSN Number Peer / Indexing status. Impact Do you use Any other No. place of Start copies (Yes/No) Refree If indexed, Name Factor/Rating. any Information publication published Reviewed of the indexing Name of the IF exclusion (Yes/No) (Yes/No) data base assigning agency. criteria for Whether covered Research by Thompson & Journals Reuter (Yes/No) 1 2 3 4 5 6 7 8 9 10 11 All Science Citation Index (SCI) Journals related to "Biological Sciences" + following journals that may or may not be included in SCI 1 3 Biotech Springer Berlin 2011 Yes Yes 2190-572X Yes Thomson and Router, 0.99 Heidelberg, Germany (Print) 2190-5738 Scopus, Google (Online) Scholar, Cross reference 2 AACL Bioflux Bioflux Publishing 2009 Yes Yes ISSN 18448143, Yes Thomson and Router, 0.5 House, Romania 18449166 Scopus, Google Scholar, Cross reference 3 ACS Chemical biology American Chemical 2006 Yes Yes 15548937, Yes Thomson and Router, 5.02 Society (United 15548929 Scopus, Google States) Scholar, Cross reference 4 ACS Synthetic Biology American Chemical 2012 Yes Yes 21615063 Yes Thomson and Router, 4.56 Society (United Scopus, Google States) Scholar, Cross reference 5 Acta Biologica Hungarica Akadémiai Kiadó, 1873 Yes Yes 0236-6495 Online Yes Thomson and Router, 0.97 Hungary ISSN: 1588-2578 Scopus, Google Scholar, Cross reference Sl.
    [Show full text]